What will health and social care look like under Andy Burnham?
This report examines some of the early signals emerging from the new Burnham Labour government and explores what it could mean for the NHS and the healthcare technology market.
03 August 2026
03 August 2026
This report examines some of the early signals emerging from the new Burnham Labour government and explores what it could mean for the NHS and the healthcare technology market.
IMPACT Therapeutics is set to receive an upfront payment, near-term regulatory milestones, and commercial milestone payments for sales.
The funding will advance its ATLAS trial, assessing lead candidate [Ac-225]RTX-2358, a FAP-targeted radiotherapeutic for advanced sarcomas.
Experts say wider patient access to CGTs hinges on further infrastructure developments and the movement of therapies into the community setting.
Sublingual semaglutide, which does not hold marketing authorisation, is touted to minimise gastric issues.
J&J strikes this deal with Sail as the in vivo CAR-T space becomes increasingly crowded.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.